Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Mora

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|April 15, 2008
LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regressionPiernanda Vigliano, Patrizia Dassi, Claudia Di Blasi, et al.
Metabolomics : Official Journal of the Metabolomic Society|June 11, 2019
NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db miceMarina Mora-Ortiz, Patricia Nuñez Ramos, Alain Oregioni, et al.
Neuromuscular Disorders : NMD|November 8, 2008
Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expressionClaudia Di Blasi, Laura Jarre, Flavia Blasevich, et al.
Genes & Diseases|February 11, 2021
A novel <i>PNPLA2</i> mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathyDaniela Tavian, Lorenzo Maggi, Marina Mora, et al.
Pediatric Neurology|September 4, 2007
Severe congenital muscular dystrophy in a LAMA2-mutated caseClaudia Di Blasi, Nens van Alfen, Francesca Colleoni, et al.
Revista Espanola De Salud Publica|December 16, 2020
[Impact of the COVID-19 pandemic on Neonatal Screening for Congenital Hypothyroidism.]Marina Mora Sitja, María Sanz Fernández, Lucía Carrascón González-Pinto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 23, 2011
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositisCristina Sancricca, Marina Mora, Enzo Ricci, et al.
Revista Espanola De Salud Publica|December 29, 2020
[Analysis of the degree of clinical suspect in patients with congenital adrenal hyperplasia by 21-hydroxylase deficiency before obtaining the result of the newborn screening program of the autonomous Community of Madrid.]María Sanz Fernández, Marina Mora Sitja, Lucía Carrascón González Pinto, et al.
BMC Genetics|September 1, 2016
Characterization of novel SSR markers in diverse sainfoin (Onobrychis viciifolia) germplasmKatharina Kempf, Marina Mora-Ortiz, Lydia M J Smith, et al.
Frontiers in Molecular Biosciences|October 18, 2016
DNAJB6 Myopathies: Focused Review on an Emerging and Expanding Group of MyopathiesAlessandra Ruggieri, Simona Saredi, Simona Zanotti, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|April 15, 2008
LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regressionPiernanda Vigliano, Patrizia Dassi, Claudia Di Blasi, et al.
Metabolomics : Official Journal of the Metabolomic Society|June 11, 2019
NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db miceMarina Mora-Ortiz, Patricia Nuñez Ramos, Alain Oregioni, et al.
Neuromuscular Disorders : NMD|November 8, 2008
Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expressionClaudia Di Blasi, Laura Jarre, Flavia Blasevich, et al.
Genes & Diseases|February 11, 2021
A novel <i>PNPLA2</i> mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathyDaniela Tavian, Lorenzo Maggi, Marina Mora, et al.
Pediatric Neurology|September 4, 2007
Severe congenital muscular dystrophy in a LAMA2-mutated caseClaudia Di Blasi, Nens van Alfen, Francesca Colleoni, et al.
Revista Espanola De Salud Publica|December 16, 2020
[Impact of the COVID-19 pandemic on Neonatal Screening for Congenital Hypothyroidism.]Marina Mora Sitja, María Sanz Fernández, Lucía Carrascón González-Pinto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 23, 2011
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositisCristina Sancricca, Marina Mora, Enzo Ricci, et al.
Revista Espanola De Salud Publica|December 29, 2020
[Analysis of the degree of clinical suspect in patients with congenital adrenal hyperplasia by 21-hydroxylase deficiency before obtaining the result of the newborn screening program of the autonomous Community of Madrid.]María Sanz Fernández, Marina Mora Sitja, Lucía Carrascón González Pinto, et al.
BMC Genetics|September 1, 2016
Characterization of novel SSR markers in diverse sainfoin (Onobrychis viciifolia) germplasmKatharina Kempf, Marina Mora-Ortiz, Lydia M J Smith, et al.
Frontiers in Molecular Biosciences|October 18, 2016
DNAJB6 Myopathies: Focused Review on an Emerging and Expanding Group of MyopathiesAlessandra Ruggieri, Simona Saredi, Simona Zanotti, et al.
Pageof 13